JPS6320828B2 - - Google Patents

Info

Publication number
JPS6320828B2
JPS6320828B2 JP59084963A JP8496384A JPS6320828B2 JP S6320828 B2 JPS6320828 B2 JP S6320828B2 JP 59084963 A JP59084963 A JP 59084963A JP 8496384 A JP8496384 A JP 8496384A JP S6320828 B2 JPS6320828 B2 JP S6320828B2
Authority
JP
Japan
Prior art keywords
general formula
compound
salt
acid
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP59084963A
Other languages
English (en)
Japanese (ja)
Other versions
JPS60228479A (ja
Inventor
Hirokazu Narita
Yoshinori Konishi
Jun Nitta
Hideyoshi Nagaki
Isao Kitayama
Yoriko Kobayashi
Mikako Shinagawa
Yasuo Watanabe
Akira Yotsuji
Shinzaburo Minami
Isamu Saikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyama Chemical Co Ltd
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13845280&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPS6320828(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Priority to JP59084963A priority Critical patent/JPS60228479A/ja
Priority to DE3546658A priority patent/DE3546658C2/de
Priority to DE19853514076 priority patent/DE3514076A1/de
Priority to GB08510297A priority patent/GB2158825B/en
Priority to PH32174A priority patent/PH22801A/en
Priority to NLAANVRAGE8501172,A priority patent/NL187314C/xx
Priority to RO126286A priority patent/RO95509B/ro
Priority to DD85275518A priority patent/DD238795A5/de
Priority to NZ211895A priority patent/NZ211895A/xx
Priority to IL7502185A priority patent/IL75021A/en
Priority to NO851643A priority patent/NO162238C/no
Priority to AT0122485A priority patent/AT389698B/de
Priority to RO118517A priority patent/RO91871B/ro
Priority to AU41650/85A priority patent/AU565087B2/en
Priority to EG261/85A priority patent/EG17339A/xx
Priority to PT80349A priority patent/PT80349B/pt
Priority to ZA853102A priority patent/ZA853102B/xx
Priority to HU851599A priority patent/HU194226B/hu
Priority to SE8502017A priority patent/SE463102B/sv
Priority to CS853035A priority patent/CS250684B2/cs
Priority to IDP980525A priority patent/ID21142A/id
Priority to FR858506327A priority patent/FR2563521B1/fr
Priority to KR1019850002822A priority patent/KR870001693B1/ko
Priority to FI851637A priority patent/FI80453C/fi
Priority to ES542584A priority patent/ES8700256A1/es
Priority to BE0/214909A priority patent/BE902279A/fr
Priority to AR85300190A priority patent/AR241911A1/es
Priority to CH1798/85A priority patent/CH673458A5/de
Priority to DK185685A priority patent/DK165877C/da
Priority to HU873675A priority patent/HU197571B/hu
Priority to IT8548002A priority patent/IT1209953B/it
Priority to PL1985253108A priority patent/PL147392B1/pl
Priority to LU85871A priority patent/LU85871A1/en
Publication of JPS60228479A publication Critical patent/JPS60228479A/ja
Priority to CS858906A priority patent/CS250698B2/cs
Priority to ES551538A priority patent/ES8706673A1/es
Priority to GB8716897A priority patent/GB2191776B/en
Priority to PH35958A priority patent/PH25046A/en
Priority to PH35960A priority patent/PH25228A/en
Priority to AU81804/87A priority patent/AU612993B2/en
Publication of JPS6320828B2 publication Critical patent/JPS6320828B2/ja
Priority to FR888808836A priority patent/FR2614620B1/fr
Priority to AT0267888A priority patent/AT390258B/de
Priority to SE8804586A priority patent/SE501412C2/sv
Priority to NL9100648A priority patent/NL9100648A/nl
Priority to NL9100647A priority patent/NL192574C/nl
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
JP59084963A 1984-04-26 1984-04-26 １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩 Granted JPS60228479A (ja)

Priority Applications (44)

Application Number Priority Date Filing Date Title
JP59084963A JPS60228479A (ja) 1984-04-26 1984-04-26 １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩
DE3546658A DE3546658C2 (enrdf_load_stackoverflow) 1984-04-26 1985-04-18
DE19853514076 DE3514076A1 (de) 1984-04-26 1985-04-18 1,4-dihydro-4-oxonaphthyridin-derivate und salze derselben, verfahren zu ihrer herstellung und antibakterielle mittel mit einem gehalt derselben
GB08510297A GB2158825B (en) 1984-04-26 1985-04-23 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof
PH32174A PH22801A (en) 1984-04-26 1985-04-23 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof and antibacterial agents comprising the same
NLAANVRAGE8501172,A NL187314C (nl) 1984-04-26 1985-04-23 Antibacterieel preparaat, alsmede een op plaats 1 gesubstitueerd 7-(3-aminopyrrolidino)-6-fluor-4-oxo-1,4-dihydro-1,8-naftyridine-3-carbonzuur derivaat.
PT80349A PT80349B (pt) 1984-04-26 1985-04-24 Processo para a preparacao de derivados de 1,4-dihidro-4-oxonaftiridina e dos seus sais e de agentes antibacterianos que os contem
RO126286A RO95509B (ro) 1984-04-26 1985-04-24 Procedeu pentru prepararea unor derivati de 1,4-dihidro-4-oxonaftiridina
DD85275518A DD238795A5 (de) 1984-04-26 1985-04-24 Verfahren zur herstellung eines 1,4-dihydro-4-oxonaphthyridin-derivate
NZ211895A NZ211895A (en) 1984-04-26 1985-04-24 1,4-dihydro-4-oxonaphthyridine derivatives, and antibacterial compositions containing such
IL7502185A IL75021A (en) 1984-04-26 1985-04-24 Acid 1-) 2,4-difluorophenyl (-6-fluoro-7-halo-1,4-dehydro-4-osco-1,8-) naphthyridene-3-carboxylate and its esters.
NO851643A NO162238C (no) 1984-04-26 1985-04-24 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater.
AT0122485A AT389698B (de) 1984-04-26 1985-04-24 Verfahren zur herstellung von neuen 1,4-dihydro-4-oxonaphthyridin-derivaten und deren salzen
RO118517A RO91871B (ro) 1984-04-26 1985-04-24 Procedeu pentru prepararea unor derivati de 1,4-dihidro-4-oxonaftiridina
AU41650/85A AU565087B2 (en) 1984-04-26 1985-04-24 1,4-dihydro-4-oxonaphthyridine derivatives
EG261/85A EG17339A (en) 1984-04-26 1985-04-24 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof
HU873675A HU197571B (en) 1984-04-26 1985-04-25 Process for production of derivatives of 1,4-dihydro-4-oxo-naftiridin, their salts and medical compositions containing these substances
KR1019850002822A KR870001693B1 (ko) 1984-04-26 1985-04-25 1,4-디하이드로-4-옥소나프티리딘 유도체의 제조방법
HU851599A HU194226B (en) 1984-04-26 1985-04-25 Process for preparing 1,4-dihydro-4-oxo-naphthyridine derivatives, their salts and pharmaceuticals comprising these compounds
SE8502017A SE463102B (sv) 1984-04-26 1985-04-25 1,4-dihydro-4-oxonaftyridinderivat och salter daerav, foerfarande foer framstaellning av dessa jaemte antibakteriella medel innefattande dessa
CS853035A CS250684B2 (en) 1984-04-26 1985-04-25 Method of 1,4-dihydro-4-oxonaphthyridine derivatives production
IDP980525A ID21142A (id) 1984-04-26 1985-04-25 Turunan 1,4-dihidro-4-oksonafitridin dan garam-garamnya, proses untuk memproduksi senyawa yang sama, dan preparat antibakteri yang tersusun dari senyawa yang sama (pecahan dari p-003498)
FR858506327A FR2563521B1 (fr) 1984-04-26 1985-04-25 Derives de la 1,4-dihydro-4-oxonaphtyridine et leurs sels, procede pour leur production et agents antibacteriens les contenant
ZA853102A ZA853102B (en) 1984-04-26 1985-04-25 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof,process for producing the same and antibacterial agents comprising the same
FI851637A FI80453C (fi) 1984-04-26 1985-04-25 Foerfarande foer framstaellning av terapeutiskt aktiva 1,4-dihydro-4-oxonaftyridinderivat.
ES542584A ES8700256A1 (es) 1984-04-26 1985-04-25 Un derivado de 1,4-dihidro-4-oxonaftiridina
BE0/214909A BE902279A (fr) 1984-04-26 1985-04-25 Derives de la 1,4-dihydro-4-oxonaphtyridine et leurs sels, procede pour leur production et agents anti-bacteriens les contenant.
AR85300190A AR241911A1 (es) 1984-04-26 1985-04-25 Procedimiento de preparacion de un derivado de 1-4-dihidro-4-oxonaftiridina.
CH1798/85A CH673458A5 (enrdf_load_stackoverflow) 1984-04-26 1985-04-25
DK185685A DK165877C (da) 1984-04-26 1985-04-25 1,4-dihydro-6-fluor-4-oxo-1,8-naphthyridin-3-carboxylsyrederivater og salte deraf, antibakterielle praeparater indeholdende saadanne forbindelser
LU85871A LU85871A1 (en) 1984-04-26 1985-04-26 1,4-DIHYDRO-4-OXONAPHTYRIDINE DERIVATIVES AND SALTS THEREOF, PROCESS FOR THEIR PREPARATION AND ANTIBACTERIAL AGENTS CONTAINING THEM
PL1985253108A PL147392B1 (en) 1984-04-26 1985-04-26 Method of obtaining novel derivatives of 1,4-dihydronaphtidrine and their salts
IT8548002A IT1209953B (it) 1984-04-26 1985-04-26 Derivati di 1,4-diidro-4-ossonaftiridina e relativi sali, procedimento per la loro produzione e agenti antibatterici che comprendono i medesimi
CS858906A CS250698B2 (cs) 1984-04-26 1985-12-05 Způsob výroby l,4-dihydro-4-oxonaftyridinových derivátů
ES551538A ES8706673A1 (es) 1984-04-26 1986-01-31 Un procedimiento para la preparacion de derivados de 1,4-dihidro-4-oxonaftiridina y sus sales
GB8716897A GB2191776B (en) 1984-04-26 1987-07-17 1, 4-dihydro-4-oxonaphthyridine derivatives and salts thereof, process for producing the same and antibacterial agents comprising the same
PH35958A PH25046A (en) 1984-04-26 1987-10-20 A process for producing 1,4-duhydro-4-oxo-naphthyridine and salts thereof
PH35960A PH25228A (en) 1984-04-26 1987-10-20 A process for producing 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof
AU81804/87A AU612993B2 (en) 1984-04-26 1987-11-25 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof, process for producing the same and antibacterial agents comprising the same
FR888808836A FR2614620B1 (fr) 1984-04-26 1988-06-30 Derives de la 1,4-dihydro-4-oxonaphtyridine et leurs sels, procede pour leur production et agents anti-bacteriens les contenant
AT0267888A AT390258B (de) 1984-04-26 1988-10-31 Verfahren zur herstellung von neuen 1,4-dihydro-4-oxonaphthydridin-derivaten und deren salzen
SE8804586A SE501412C2 (sv) 1984-04-26 1988-12-20 1,4-dihydro-4-oxonaftyridinderivat och salter därav förfarande för framställning av dessa jämte antibakteriella medel innefattande dessa
NL9100648A NL9100648A (nl) 1984-04-26 1991-04-15 Antibacterieel preparaat, alsmede een op plaats 1 gesubstitueerd 7-(cyclisch amino)-6-fluor-4-oxo-1,4-dihydro-1,8-naftyridine-3-carbonzuurderivaat.
NL9100647A NL192574C (nl) 1984-04-26 1991-04-15 Antibacterieel preparaat, alsmede een op plaats 1 gesubstitueerd 7-(3-gesubstitueerd-1-pyrrolidinyl)-6-fluor-4-oxo-1,4-dihydro -1,8-naftyridine-3-carbonzuurderivaat.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59084963A JPS60228479A (ja) 1984-04-26 1984-04-26 １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩

Related Child Applications (3)

Application Number Title Priority Date Filing Date
JP60239523A Division JPS61143383A (ja) 1985-10-28 1985-10-28 １，４−ジヒドロ−４−オキソナフチリジン誘導体またはその塩を含有する抗菌剤
JP60239522A Division JPS61137819A (ja) 1985-10-28 1985-10-28 １，４−ジヒドロ−４−オキソナフチリジン誘導体またはその塩を含有する抗菌剤
JP62254530A Division JPH0633262B2 (ja) 1987-10-12 1987-10-12 １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩

Publications (2)

Publication Number Publication Date
JPS60228479A JPS60228479A (ja) 1985-11-13
JPS6320828B2 true JPS6320828B2 (enrdf_load_stackoverflow) 1988-04-30

Family

ID=13845280

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59084963A Granted JPS60228479A (ja) 1984-04-26 1984-04-26 １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩

Country Status (30)

Country Link
JP (1) JPS60228479A (enrdf_load_stackoverflow)
KR (1) KR870001693B1 (enrdf_load_stackoverflow)
AR (1) AR241911A1 (enrdf_load_stackoverflow)
AT (2) AT389698B (enrdf_load_stackoverflow)
AU (2) AU565087B2 (enrdf_load_stackoverflow)
BE (1) BE902279A (enrdf_load_stackoverflow)
CH (1) CH673458A5 (enrdf_load_stackoverflow)
CS (1) CS250684B2 (enrdf_load_stackoverflow)
DD (1) DD238795A5 (enrdf_load_stackoverflow)
DE (2) DE3546658C2 (enrdf_load_stackoverflow)
DK (1) DK165877C (enrdf_load_stackoverflow)
EG (1) EG17339A (enrdf_load_stackoverflow)
ES (2) ES8700256A1 (enrdf_load_stackoverflow)
FI (1) FI80453C (enrdf_load_stackoverflow)
FR (2) FR2563521B1 (enrdf_load_stackoverflow)
GB (2) GB2158825B (enrdf_load_stackoverflow)
HU (2) HU197571B (enrdf_load_stackoverflow)
ID (1) ID21142A (enrdf_load_stackoverflow)
IL (1) IL75021A (enrdf_load_stackoverflow)
IT (1) IT1209953B (enrdf_load_stackoverflow)
LU (1) LU85871A1 (enrdf_load_stackoverflow)
NL (2) NL187314C (enrdf_load_stackoverflow)
NO (1) NO162238C (enrdf_load_stackoverflow)
NZ (1) NZ211895A (enrdf_load_stackoverflow)
PH (3) PH22801A (enrdf_load_stackoverflow)
PL (1) PL147392B1 (enrdf_load_stackoverflow)
PT (1) PT80349B (enrdf_load_stackoverflow)
RO (2) RO95509B (enrdf_load_stackoverflow)
SE (2) SE463102B (enrdf_load_stackoverflow)
ZA (1) ZA853102B (enrdf_load_stackoverflow)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6172753A (ja) * 1984-09-18 1986-04-14 Dainippon Pharmaceut Co Ltd ピリジルケトン誘導体
AT392789B (de) * 1985-01-23 1991-06-10 Toyama Chemical Co Ltd Verfahren zur herstellung von 1-substituierten aryl-1,4-dihydro-4-oxonaphthyridinderivaten
AU576657B2 (en) * 1985-01-23 1988-09-01 Toyama Chemical Co. Ltd. Naphthyridine and pyridine derivatives
DE3525108A1 (de) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen Antibakteriell wirksame chinoloncarbonsaeureester
IL79189A (en) * 1985-06-26 1990-07-12 Daiichi Seiyaku Co Quinoline and/or naphthyridine-4-oxo-3-carboxylic acid derivatives,process for their preparation and pharmaceutical compositions comprising them
IE62600B1 (en) * 1987-08-04 1995-02-22 Abbott Lab Naphtyridine antianaerobic compounds
US4962112A (en) * 1987-08-04 1990-10-09 Abbott Laboratories 7-(2-methyl-4-aminopyrrolidinyl)naphthryidine and quinoline compounds
US4859776A (en) * 1988-03-11 1989-08-22 Abbott Laboratories (S)-7-(3-aminopyrrolidin-1-yl)-1-(ortho, para-difluorophenyl)-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid and method for its preparation
JP2844079B2 (ja) * 1988-05-23 1999-01-06 塩野義製薬株式会社 ピリドンカルボン酸系抗菌剤
DE3934082A1 (de) * 1989-10-12 1991-04-18 Bayer Ag Chinoloncarbonsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung als antivirale mittel
EP0571400A1 (en) * 1991-01-14 1993-12-01 Hanmi Pharmaceutical Co.,Ltd. Novel quinolone compounds and processes for preparation thereof
FR2692577B1 (fr) * 1992-05-26 1996-02-02 Bouchara Sa Nouvelles quinolones fluorees, leur procede de preparation et les compositions pharmaceutiques en renfermant.
KR940014395A (ko) * 1992-12-09 1994-07-18 강박광 신규한 퀴놀론 유도체 및 그의 제조방법
KR0148277B1 (ko) * 1993-01-18 1998-11-02 채영복 신규한 플루오르퀴놀론계 유도체 및 그의 제조방법
AU4272793A (en) * 1993-04-24 1994-11-21 Korea Research Institute Of Chemical Technology Novel quinolone carboxylic acid derivatives and process for preparing the same
KR950018003A (ko) * 1993-12-09 1995-07-22 스미스클라인 비참 피엘씨 신규한 퀴놀론 유도체 및 그의 제조 방법
WO1996012704A1 (fr) * 1994-10-20 1996-05-02 Wakunaga Seiyaku Kabushiki Kaisha Nouveau derive de pyridone-carboxylate, ou sel de celui-ci, et antibacterien le contenant comme principe actif
EP0897919B1 (en) 1996-04-19 2004-06-16 Wakunaga Pharmaceutical Co., Ltd. Novel pyridonecarboxylic acid derivatives or salts thereof and antibacterial agents containing the same as the active ingredient
PL332941A1 (en) * 1996-10-30 1999-10-25 Bayer Ag Method of obtaining naphtyridinic compounds and novel intermediate compounds
DE19713506A1 (de) 1997-04-01 1998-10-08 Bayer Ag Verfahren zur Herstellung von 2,6-Dichlor-5-fluornicotinonitril und die chemische Verbindung 3-Cyano-2-hydroxy-5-fluorpyrid-6-on-mononatriumsalz sowie dessen Tautomere
WO2000054811A1 (fr) 1999-03-17 2000-09-21 Daiichi Pharmaceutical Co., Ltd. Compositions medicamenteuses
DE19926400A1 (de) 1999-06-10 2000-12-14 Bayer Ag Verbessertes Verfahren zur Herstellung von 2,6-Dichlor-5-fluor-nicotinsäure und grobteilige und besonders reine 2,6-Dichlor-5-fluor-nicotinsäure
EP1219618A4 (en) 1999-09-02 2002-09-18 Wakunaga Pharma Co Ltd QUINOLINECARBOXYLIC ACID DERIVATIVE OR ITS SALT
AU2001286852A1 (en) * 2000-08-29 2002-03-13 Chiron Corporation Quinoline antibacterial compounds and methods of use thereof
KR100981351B1 (ko) * 2003-10-29 2010-09-10 주식회사 엘지생명과학 7-클로로-1-사이클로프로필-6-플루오로-4-옥소-1,4-디하이드로-1,8-나프티리딘-3-카복실산의 제조방법
CN101792443A (zh) * 2010-03-09 2010-08-04 北京欧凯纳斯科技有限公司 氟代喹诺酮衍生物及其制备方法和用途
JOP20190045A1 (ar) 2016-09-14 2019-03-14 Bayer Ag مركبات أميد حمض 1- أريل-نفثيريدين-3-كربوكسيليك مستبدلة في الموضع 7 واستخدامها.
CN114369092A (zh) * 2021-12-20 2022-04-19 赤峰万泽药业股份有限公司 甲苯磺酸妥舒沙星及其制备方法
CN116606279A (zh) * 2023-03-13 2023-08-18 广东工业大学 一种氟喹诺酮类化合物及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2125310A1 (en) * 1971-05-21 1972-11-30 Sterling Drug Inc , New York, NY (V St A) 1-alkyl-1,4-dihydro-4-oxo-1,8-naphtyridine 3-carboxylic acids antibac
AR223983A1 (es) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
DE3033157A1 (de) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4382937A (en) 1981-02-27 1983-05-10 Dainippon Pharmaceutical Co., Ltd. Naphthyridine derivatives and their use as anti-bacterials
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
NZ210847A (en) * 1984-01-26 1988-02-29 Abbott Lab Naphthyridine and pyridopyrimidine derivatives and pharmaceutical compositions
IL74064A (en) * 1984-01-26 1988-09-30 Abbott Lab 1,7-disubstituted-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivatives and antibacterial compositions containing them
AU576657B2 (en) * 1985-01-23 1988-09-01 Toyama Chemical Co. Ltd. Naphthyridine and pyridine derivatives
DE3525108A1 (de) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen Antibakteriell wirksame chinoloncarbonsaeureester

Also Published As

Publication number Publication date
FI851637L (fi) 1985-10-27
SE501412C2 (sv) 1995-02-13
RO91871A (ro) 1987-07-30
NZ211895A (en) 1988-07-28
IL75021A0 (en) 1985-08-30
DE3514076C2 (enrdf_load_stackoverflow) 1989-03-30
KR870001693B1 (ko) 1987-09-24
NO162238C (no) 1989-12-06
JPS60228479A (ja) 1985-11-13
ES8700256A1 (es) 1986-09-16
GB2191776B (en) 1990-03-28
ES551538A0 (es) 1987-07-01
GB2158825B (en) 1989-01-25
IT1209953B (it) 1989-08-30
RO95509B (ro) 1988-10-01
SE463102B (sv) 1990-10-08
AT390258B (de) 1990-04-10
PH25228A (en) 1991-03-27
IL75021A (en) 1994-01-25
IT8548002A0 (it) 1985-04-26
HUT38634A (en) 1986-06-30
AT389698B (de) 1990-01-10
EG17339A (en) 1989-06-30
FI851637A0 (fi) 1985-04-25
GB8716897D0 (en) 1987-08-26
SE8502017L (sv) 1985-10-27
LU85871A1 (en) 1985-12-16
ATA122485A (de) 1989-06-15
CS250684B2 (en) 1987-05-14
PT80349A (en) 1985-05-01
FR2614620A1 (fr) 1988-11-04
DK185685D0 (da) 1985-04-25
AR241911A1 (es) 1993-01-29
PL147392B1 (en) 1989-05-31
KR850007596A (ko) 1985-12-07
RO91871B (ro) 1987-07-31
ZA853102B (en) 1986-12-30
FR2563521B1 (fr) 1989-02-03
ES542584A0 (es) 1986-09-16
ATA267888A (de) 1989-09-15
CH673458A5 (enrdf_load_stackoverflow) 1990-03-15
FR2563521A1 (fr) 1985-10-31
DE3514076A1 (de) 1985-10-31
NL187314C (nl) 1991-08-16
HU194226B (en) 1988-01-28
PL253108A1 (en) 1985-12-17
NL9100648A (nl) 1991-08-01
NO162238B (no) 1989-08-21
DK185685A (da) 1985-10-27
NL8501172A (nl) 1985-11-18
AU565087B2 (en) 1987-09-03
HU197571B (en) 1989-04-28
DE3546658C2 (enrdf_load_stackoverflow) 1992-04-02
FI80453C (fi) 1990-06-11
SE8804586L (sv) 1988-12-20
RO95509A (ro) 1988-09-30
ID21142A (id) 1999-04-29
AU4165085A (en) 1985-10-31
NO851643L (no) 1985-10-28
FI80453B (fi) 1990-02-28
DK165877B (da) 1993-02-01
PH22801A (en) 1988-12-12
SE8502017D0 (sv) 1985-04-25
SE8804586D0 (sv) 1988-12-20
DK165877C (da) 1993-06-21
PH25046A (en) 1991-01-28
GB8510297D0 (en) 1985-05-30
GB2158825A (en) 1985-11-20
BE902279A (fr) 1985-10-25
FR2614620B1 (fr) 1990-03-09
PT80349B (pt) 1987-09-30
DD238795A5 (de) 1986-09-03
AU612993B2 (en) 1991-07-25
ES8706673A1 (es) 1987-07-01
GB2191776A (en) 1987-12-23
AU8180487A (en) 1988-03-24

Similar Documents

Publication Publication Date Title
JPS6320828B2 (enrdf_load_stackoverflow)
EP0324298B1 (fr) Dérivés des acides 7-(1-azétidinyl)-1,4-dihydro-4-oxoquinoléine-3-carboxyliques, leur préparation et leur application en tant que médicaments
KR880001816B1 (ko) 세팔로스포린 유도체의 제조방법
DK147513B (da) Analogifremgangsmaade til fremstilling af cefuroximestere
US5728691A (en) Quinolonylcarboxamidocephalosporin derivatives and pharmaceutical compositions containing them
JP2787713B2 (ja) 新規なイソチアゾローナフチリジンおよびイソチアゾローキノリン誘導体並びにそれらの塩
JPH0544949B2 (enrdf_load_stackoverflow)
JP2704428B2 (ja) キノロンカルボン酸誘導体またはその塩
JPS62103092A (ja) β−ラクタム誘導体
JPH0811749B2 (ja) 新規なキノリン誘導体およびその塩
JPH0578556B2 (enrdf_load_stackoverflow)
JPS6270370A (ja) キノロンカルボン酸誘導体およびその製造方法
JPS6237006B2 (enrdf_load_stackoverflow)
JPH0753565A (ja) 新規セファロスポリン系抗生物質及びその製造方法
JP2654581B2 (ja) 新規な１，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩
JPH0543464A (ja) ピリドンカルボン酸誘導体またはその塩を含有する抗菌剤
JPH0717643B2 (ja) 新規なナフチリジン誘導体およびその塩
US5416081A (en) Cephalosporin compounds
JP2630566B2 (ja) １，４−ジヒドロー４−オキソナフチリジン誘導体またはその塩
KR970001159B1 (ko) 신규 1,8-나프티리딘 유도체 및 그의 제조방법
JPH0633262B2 (ja) １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩
JP3140525B2 (ja) 新規なセファロスポリン誘導体およびその塩
KR100236852B1 (ko) 플루오로 퀴놀린 유도체
JPH0348682A (ja) ピリドンカルボン酸化合物
KR0154902B1 (ko) 신규 세팔로스포린계 항생제(iv)

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term